The lives of almost 4 million women, newborns, and children in sub-Saharan Africa could be saved every year if well-established, affordable health care interventions reached 90 percent of families, according to a joint report by the national science academies of seven African countries. Many African nations are underutilizing existing scientific knowledge to save lives, says [...]

The fifth annual international conference of the African Science Academy Development Initiative (ASADI) will be held Nov. 9-11 in Accra, Ghana, in conjunction with the 50th anniversary of the Ghana Academy of Arts and Sciences. The theme of this year’s conference will be improving maternal, newborn, and child health in Africa, which will be discussed [...]

Depomed, Inc. (NASDAQ:DEPO) announced that it has dosed the first patient in a Phase I trial for its DM-1992 program in Parkinson’s disease based on positive results from preclinical studies sponsored by The Michael J. Fox Foundation for Parkinson’s Research. DM-1992 is an investigative novel gastric retentive extended-release dosage form of Levodopa/Carbidopa, a marketed therapy [...]

Researchers at The University of Texas Health Science Center at Houston have received a $325,000 award from The Michael J. Fox Foundation for Parkinson’s Research to develop a vaccine for this progressive neurological disorder that affects about a million Americans.

KineMed, Inc., a pathway-based drug discovery and development company, has been awarded a grant of up to $694,441 (if all milestones are met) to conduct clinical studies toward a new biomarker-based treatment for Parkinson’s disease (PD). The funding, awarded under the Foundation’s Therapeutics Development Initiative, enables KineMed to assess if its proprietary biomarker measurements of [...]